Phibro Animal Health (PAHC) Short-term Investments (2017 - 2026)

Phibro Animal Health's Short-term Investments history runs 10 years deep, the most recent figure standing at $22.5 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 125.22% year-over-year to $22.5 million; the TTM figure through Mar 2026 stood at $22.5 million (up 125.22% YoY), while the FY2025 annual figure was $9.0 million, down 79.55% from the prior year.
• Short-term Investments was $22.5 million for Q1 2026 at Phibro Animal Health, up from $19.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $59.5 million in Q4 2023 to a low of $9.0 million in Q2 2025.
• Historically, Short-term Investments has averaged $27.7 million across 5 years, with a median of $20.8 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments plunged 82.14% in 2022, then surged 495.23% in 2023.
• A 5-year view of Short-term Investments shows it stood at $10.0 million in 2022, then soared by 495.23% to $59.5 million in 2023, then tumbled by 36.16% to $38.0 million in 2024, then sank by 49.94% to $19.0 million in 2025, then grew by 18.4% to $22.5 million in 2026.
• The last three Short-term Investments figures came in at $22.5 million (Q1 2026), $19.0 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.